Optibrium launches a metabolism prediction software platform tailored to DMPK scientists

Semeta™ offers high sensitivity and superior precision for the prediction of Phase I and II metabolic routes, sites, products and liabilities in early drug discove.ry

Environmental stressors linked to fetal brain development challenges

Review article in the journal Antioxidants explores the impact of environmental factors on fetal and neonatal brain development, emphasizing the role of inflammation and oxidative

April 16, 2024

AbbVie puts $161M into new R&D site in Germany, will add 300 jobs

AbbVie is investing around €150 million ($161 million) into an R&D site at its Rhineland-Palatinate location in Germany which it expects to complete in 2027,

May 4, 2024

China’s NMPA approves Antengene’s XPOVIO for DLBCL treatment

One of the most prevalent subtypes of adult non-Hodgkin lymphoma is diffuse large B-cell lymphoma. Credit: Nemes Laszlo/ Shutterstock. China’s National Medical Products Administration (NMPA)

July 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.